Semler Scientific Adopts Bitcoin as Primary Treasury Reserve Asset, Shares Surge

Semler Scientific, a medical technology company, made headlines on Tuesday as its shares surged after announcing its adoption of bitcoin as its primary treasury reserve asset. The company, known for developing products used in the detection of peripheral arterial disease, also revealed that it had purchased 581 bitcoins for approximately $40 million.

This move by Semler follows in the footsteps of MicroStrategy, a company that has been actively investing in bitcoin and has seen significant gains as a result. Eric Semler, the chairman of Semler Scientific, emphasized the company’s belief in bitcoin as a reliable store of value and a compelling investment.

The decision to incorporate bitcoin into its treasury strategy has propelled Semler’s stock price up by 30% on Tuesday, despite a slight dip in the price of bitcoin itself. With a market capitalization of around $210 million, Semler has experienced a 30% decline in its stock value this year.

By aligning itself with the likes of MicroStrategy, Semler aims to capitalize on the potential for bitcoin to act as an inflation hedge and safe haven asset amid global instability. The company plans to continue focusing on its core medical products and services while evaluating the use of excess cash generated from sales of its blood flow tests.

Other notable companies, such as Tesla and Block, have also integrated bitcoin into their balance sheets. As bitcoin continues to rise in value and gain acceptance, the trend of corporate treasuries adopting the cryptocurrency is seen as a significant indicator of institutional adoption.

Despite the potential benefits of holding bitcoin, regulatory uncertainty and environmental, social, and governance (ESG) considerations have hindered widespread adoption among corporate entities. Nevertheless, Semler’s bold move to embrace bitcoin signals a growing trend in the financial world towards digital assets as a viable investment option.